[Clinical management of patients with sepsis].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Der Anaesthesist

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12577161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated protein C for severe sepsis.

  2002cited by this paper
• A phase II randomized, controlled trial of continuous hemofiltration in sepsis

  2002cited by this paper
• Low-dose heparin for severe sepsis.

  2002cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?

  2002cited by this paper
• [Arginine vasopressin in vasodilatory shock: a new therapy approach?].

  2002cited by this paper
• Association between mitochondrial dysfunction and severity and outcome of septic shock.

  2002cited by this paper
• Use of echocardiography for hemodynamic monitoring

  2002cited by this paper
• Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock*

  2002cited by this paper
• Immunological therapy in sepsis: currently available

  2001cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?

  2001cited by this paper
• [Colloids in intensive care].

  2001cited by this paper
• Advances in mechanical ventilation.

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

  2001cited by this paper
• The pathogenesis of vasodilatory shock.

  2001cited by this paper
• A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

  2001cited by this paper
• Effect of prone positioning on the survival of patients with acute respiratory failure.

  2001cited by this paper
• Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

  2001cited by this paper
• Low levels of protein C are associated with poor outcome in severe sepsis.

  2001cited by this paper
• Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

  2001cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients

  2001cited by this paper
• Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.

  2001cited by this paper
• Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

  2001cited by this paper
• Corticosteroids for septic shock

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• TREM-1 amplifies inflammation and is a crucial mediator of septic shock

  2001cited by this paper
• Antibiotics in sepsis

  2001cited by this paper
• Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties.

  2001cited by this paper
• Endothelial protein C activation in meningococcal sepsis.

  2001cited by this paper
• Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

  2001cited by this paper
• Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

  2000cited by this paper
• Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia

  2000cited by this paper
• Thrombin signalling and protease-activated receptors

  2000cited by this paper
• A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

  2000cited by this paper
• Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia

  2000cited by this paper
• Protein C substitution in sepsis-associated purpura fulminans

  2000cited by this paper
• Protection from septic shock by neutralization of macrophage migration inhibitory factor

  2000cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Acute Necrotizing Pancreatitis: Treatment Strategy According to the Status of Infection

  2000cited by this paper
• [Catecholamine therapy in sepsis] .

  2000cited by this paper
• Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

  2000cited by this paper
• Ionized hypocalcemia during sepsis.

  2000cited by this paper
• Inhaled nitric oxide does not enhance lipid peroxidation in patients with acute respiratory distress syndrome

  2000cited by this paper
• Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis.

  1999cited by this paper
• Sepsis research: we must change course.

  1999cited by this paper
• Noninvasive ventilation: experience at a community teaching hospital

  1999cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Early enteral nutritional support improves outcome: hypothesis or fact?

  1999cited by this paper
• Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

  1999cited by this paper
• Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine.

  1999cited by this paper
• Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

  1999cited by this paper
• Increased mortality associated with growth hormone treatment in critically ill adults.

  1999cited by this paper
• Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.

  1999cited by this paper
• Acute necrotizing pancreatitis.

  1999cited by this paper
• Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock.

  1999cited by this paper
• Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

  1998cited by this paper
• Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

  1998cited by this paper
• A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.

  1998cited by this paper
• Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

  1998cited by this paper
• Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.

  1998cited by this paper
• Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

  1998cited by this paper
• Interpretation of blood lactate concentrations in patients with sepsis.

  1998cited by this paper
• Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

  1998cited by this paper
• Effects of vasoactive drugs on gastric intramucosal pH.

  1998cited by this paper
• Vasopressin deficiency contributes to the vasodilation of septic shock.

  1997cited by this paper
• The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

  1997cited by this paper
• Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

  1997cited by this paper
• p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

  1997cited by this paper
• Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study

  1997cited by this paper
• Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.

  1997cited by this paper
• Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients.

  1997cited by this paper
• Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.

  1997cited by this paper
• Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians.

  1997cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Noninvasive positive-pressure ventilation in acute respiratory distress without prior chronic respiratory failure.

  1996cited by this paper
• Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

  1996cited by this paper
• Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

  1996cited by this paper
• Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.

  1996cited by this paper
• INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

  1996cited by this paper
• Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.

  1996cited by this paper
• A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

  1996cited by this paper
• The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.

  1996cited by this paper
• Methylene blue administration in septic shock: a clinical trial.

  1995cited by this paper
• Steroid controversy in sepsis and septic shock: a meta-analysis.

  1995cited by this paper
• Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

  1995cited by this paper
• CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.

  1995cited by this paper
• Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill.

  1995cited by this paper
• Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

  1995cited by this paper
• A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.

  1995cited by this paper
• Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

  1994cited by this paper
• Elevation of systemic oxygen delivery in the treatment of critically ill patients.

  1994cited by this paper
• Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

  1994cited by this paper
• Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS).

  1994cited by this paper
• Initial evaluation of human recombinant interleukin‐1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open‐label, placebocontrolled multicenter trial

  1994cited by this paper
• Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group.

  1994cited by this paper
• Search for sepsis drugs goes on despite past failures.

  1994cited by this paper
• Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.

  1993cited by this paper

• Exploring the mechanisms of mutual influence between lactylation and macrophage polarization in the context of disease

  2025cites this paper
• Soluble Intercellular Adhesion Molecule- (sICAM-) 1, Thrombospondin-1, and Vinculin for the Identification of Septic Shock Patients Suffering from an Invasive Fungal Infection

  2020cites this paper
• Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock

  2019cites this paper
• Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock—Results of a Combined Clinical and Experimental Investigation

  2017cites this paper
• Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients

  2015cites this paper
• Prospective evaluation of regional oxygen saturation to estimate central venous saturation in sepsis

  2015influential citation
• L-Arginine and Asymmetric Dimethylarginine Are Early Predictors for Survival in Septic Patients with Acute Liver Failure

  2012cites this paper
• The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.

  2012cites this paper
• Viral infections in septic shock (VISS-trial)-crosslinks between inflammation and immunosuppression.

  2012cites this paper
• [Near-infrared spectroscopy in sepsis therapy : predictor of a low central venous oxygen saturation].

  2012cites this paper
• Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.

  2010cites this paper
• Sepsis-Induced Degradation of Endothelial Glycocalix

  2010cites this paper
• Redox Responses in Patients with Sepsis: High Correlation of Thioredoxin-1 and Macrophage Migration Inhibitory Factor Plasma Levels

  2010cites this paper
• Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction

  2009cites this paper
• Schwere Sepsis und disseminierte intravasale Gerinnung

  2009cites this paper
• Left ventricular end-diastolic area is a measure of cardiac preload in patients with early septic shock

  2009cites this paper
• Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia

  2007cites this paper
• [Non-invasive extended hemodynamic monitoring. Reduction of circulatory risk situations].

  2007cites this paper
• Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

  2006cites this paper
• Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

  2006cites this paper
• [Surgical focal treatment].

  2006cites this paper
• [Sepsis and multiple organ failure - update of current therapeutic concepts].

  2005cites this paper
• Intensive care management of acute liver failure.

  2004cites this paper
• Bedeutung der angeborenen Immunantwort in der Sepsis

  2004cites this paper
• The systemic inflammatory response syndrome.

  2004cites this paper
• Intensive care

  2004cites this paper
• The role of Ca++-sensitizers for the treatment of heart failure

  2003cites this paper
• [New pathways and current concepts in intensive care medicine--a summary of important articles of the last month].

  2003cites this paper
• [Sepsis therapy. A dilemma in times of limited financial resources].

  2003cites this paper